Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes a Randomized Controlled Trial

What this Trial Is About

Researchers are evaluating if using a continuous glucose monitoring CGM system helps improve blood sugar control in older adults with type 2 diabetes who manage their condition with oral medications only. This study compares continuous glucose monitoring to the standard fingerstick blood glucose monitoring to see which method better manages glucose levels and affects psychological well-being in this population. Participants will be assigned to one of two groups the CGM group will use a CGM sensor every two months and be instructed on its use, including checking blood glucose when symptoms do not match CGM readings. The blood glucose meter BGM group will use a fingerstick glucose meter about twice a week but can check more often if desired. The study lasts six months with follow-up visits every two months. During the study, participants will visit the clinic every two months for check-ups and keep a glucose diary when not using CGM. Researchers will measure changes in HbA1c after 24 weeks, along with time spent in blood glucose target ranges, glucose variability, and average glucose levels. This trial is sponsored by Shanghai 6th Peoples Hospital and runs until mid-2027.

Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes